Franklin Genomic Advancements ETF (HELX) Institutional Ownership $25.76 -1.36 (-5.03%) Closing price 05/23/2025 03:53 PM EasternExtended Trading$25.76 0.00 (0.00%) As of 05/23/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Institutional Ownership Changes (13F Filings) for Franklin Genomic Advancements ETF (BATS:HELX)Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$1.62MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$904.66K Get HELX Insider Trade Alerts Want to know when executives and insiders are buying or selling Franklin Genomic Advancements ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data HELX Institutional Buying and Selling by Quarter Franklin Genomic Advancements ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025 Jane Street Group LLC8,049$217K0.0%-80.4%2.012% 5/8/2025 Harbour Investments Inc.1,823$49K0.0%+1,240.4%0.456% 4/18/2025 Halbert Hargrove Global Advisors LLC2,554$69K0.0%+41.8%0.639% 2/17/2025 Citadel Advisors LLC7,966$230K0.0%N/A2.655% 2/14/2025 Jane Street Group LLC41,030$1.18M0.0%N/A13.677% 2/11/2025 LPL Financial LLC16,965$489K0.0%+19.5%5.655% 2/5/2025 Halbert Hargrove Global Advisors LLC1,801$52K0.0%N/A0.600% 7/31/2024 Commonwealth Equity Services LLC6,677$212K0.0%-5.2%2.226% 1/26/2023Vigilant Capital Management LLC900$27K0.0%N/A0.000% (Data available from 1/1/2016 forward) HELX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of HELX shares? During the previous two years, the following institutional investors and hedge funds held shares of Franklin Genomic Advancements ETF shares: LPL Financial LLC ($489K), Citadel Advisors LLC ($230K), Jane Street Group LLC ($217K), Commonwealth Equity Services LLC ($212K), and Halbert Hargrove Global Advisors LLC ($69K), Harbour Investments Inc. ($49K).Learn more on HELX's institutional investors. Which institutional investors have been buying Franklin Genomic Advancements ETF stock? The following institutional investors have purchased Franklin Genomic Advancements ETF stock in the last 24 months: Jane Street Group LLC ($41.03K), Citadel Advisors LLC ($7.97K), LPL Financial LLC ($2.77K), Halbert Hargrove Global Advisors LLC ($2.55K), and Harbour Investments Inc. ($1.69K). How much institutional buying is happening at Franklin Genomic Advancements ETF? Institutional investors have bought a total of 56,005 shares in the last 24 months. This purchase volume represents approximately $1.62M in transactions. Which Franklin Genomic Advancements ETF major shareholders have been selling company stock? The following institutional investors have sold Franklin Genomic Advancements ETF stock in the last 24 months: Jane Street Group LLC ($32.98K), and Commonwealth Equity Services LLC ($365.00). How much institutional selling is happening at Franklin Genomic Advancements ETF? Institutional investors have sold a total of 33,346 shares in the last 24 months. This volume of shares sold represents approximately $904.66K in transactions. Related Companies GXTG Major Shareholders NIKL Major Shareholders AQWA Major Shareholders GCLN Major Shareholders SATO Major Shareholders EQRR Major Shareholders MSOX Major Shareholders MNTL Major Shareholders FIVY Major Shareholders ESIX Major Shareholders This page (BATS:HELX) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HELX Stock Free HELX Stock Alerts